- Trials with a EudraCT protocol (993)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (15)
993 result(s) found for: Risk Factors.
Displaying page 1 of 50.
EudraCT Number: 2013-003514-40 | Sponsor Protocol Number: TromsøEndo-2013-1 | Start Date*: 2013-09-17 |
Sponsor Name:University Hospital of North Norway | ||
Full Title: The effect of vitamin D supplementation on cardiovascular risk factors in subjects with low serum 25-hydroxyvitamin D levels | ||
Medical condition: subjects with serum 25-hydroxyvitamin D < 35 nmol/L will be included and the effect of vitamin D supplementation versus placebo tested regarding cardiovascular risk factors | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004739-38 | Sponsor Protocol Number: NL51093.029.14 | Start Date*: 2015-03-09 |
Sponsor Name:VU Univeristy Medical Centre | ||
Full Title: Follow-up of the FRUIT-RCT; aspirin resistance and cardiovascular risk factors in women after recurrent hypertensive disorders in pregnancy | ||
Medical condition: Hypertensive disorders of pregnancy; aspirin resistance and cardiovascular risk factors. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002644-32 | Sponsor Protocol Number: EFC14875 | Start Date*: 2017-11-14 | ||||||||||||||||
Sponsor Name:SANOFI-AVENTIS RECHERCHE ET DEVELOPPEMENT | ||||||||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Effects of Sotagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes, Ca... | ||||||||||||||||||
Medical condition: Type 2 diabetes mellitus Chronic kidney disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Prematurely Ended) LV (Completed) GB (Completed) HU (Completed) SE (Completed) NO (Completed) FR (Completed) NL (Completed) DK (Completed) ES (Prematurely Ended) LT (Completed) EE (Completed) PT (Completed) BE (Completed) GR (Completed) BG (Completed) IT (Completed) RO (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-002942-20 | Sponsor Protocol Number: EFC5826 | Start Date*: 2005-12-29 | |||||||||||
Sponsor Name:sanofi-aventis recherche et developpement | |||||||||||||
Full Title: Randomized, multinational, multicenter, double-blind, placebo-controlled, two-arm parallel group trial of rimonabant 20 mg OD for reducing the risk of major cardiovascular events in abdominally obe... | |||||||||||||
Medical condition: Patients with abdominal obesity at increased risk for cardiovascular events (myocardial infarctio, stroke and cardiovascular death) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prohibited by CA) GB (Prematurely Ended) ES (Completed) DE (Completed) AT (Prematurely Ended) FI (Completed) BE (Completed) DK (Suspended by CA) HU (Completed) CZ (Suspended by CA) IE (Prematurely Ended) PT (Completed) GR (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004086-15 | Sponsor Protocol Number: 1000 | Start Date*: 2005-05-17 |
Sponsor Name:University Hospital of Frankfurt, Department of Cardiology | ||
Full Title: Comparison of nephrotoxic effects of the contrast dyes iodixanol (iso-osmolar, non-ionic, dimer) and ioversol (low-osmolar, non-ionic, monomer) in patients with impaired renal function and severe h... | ||
Medical condition: Coronary angiography in patients with known coronary artery disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005066-36 | Sponsor Protocol Number: 12-17 | Start Date*: 2013-05-15 |
Sponsor Name:VU University Medical Center | ||
Full Title: Effect of Growth Hormone replacement therapy on cardiovascular risk factors in adult patients with severe growth hormone deficiency: association with IGF-I concentration | ||
Medical condition: Growth hormone deficiency | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000452-14 | Sponsor Protocol Number: FARM537JNE | Start Date*: 2007-08-29 | |||||||||||
Sponsor Name:CONSORZIO MARIO NEGRI SUD | |||||||||||||
Full Title: Long term impact of renin angiotensin system RAS inhibition on cardiorenal outcomes. A randomized controlled trial of cardio-renal effects of RAS inhibition in patients with cardio-renal risk. A... | |||||||||||||
Medical condition: Patients with one or more cardiovascular risk factors and microalbuminuria, diabetic or not diabetic. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-004555-30 | Sponsor Protocol Number: 1903-004 | Start Date*: 2009-04-28 | |||||||||||
Sponsor Name:Merck Sharp & Dohme (Sweden) AB | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Lipid-Modifying Effect and Tolerability of MK-1903 in Patients with Dyslipidemia | |||||||||||||
Medical condition: Dyslipidemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000647-32 | Sponsor Protocol Number: PRIOTAB | Start Date*: 2014-10-22 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: Investigation of the efficacy of degarelix as an acute treatment for patients with pedophilic disorder to reduce the risk for sexual child molestation: a prospective, randomized, double blind, and ... | ||
Medical condition: Pedophilia acccording to DSM-5 (F65.4) | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-004953-14 | Sponsor Protocol Number: 0653-139 | Start Date*: 2009-01-16 | |||||||||||
Sponsor Name:Merck & Co., Inc. | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Titration Study to Evaluate and Compare the Efficacy and Safety of Ezetimibe 10 mg Added on to Rosuvastatin 5 mg, 10 mg, 20 mg, or 40 mg Versus Up-Titration... | |||||||||||||
Medical condition: hypercholesterolemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) FI (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004466-34 | Sponsor Protocol Number: 18-07 | Start Date*: 2019-05-16 |
Sponsor Name:Amsterdam UMC VUmc | ||
Full Title: Tau PET imaging in cognitively normal elderly subjects: A twin approach | ||
Medical condition: Cognitively healthy elderly, aged 60-100 years old. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002846-30 | Sponsor Protocol Number: NLG-LBC-06 | Start Date*: 2016-09-13 | |||||||||||
Sponsor Name:HUS-The Hospital District of Helsinki and Uusimaa | |||||||||||||
Full Title: BIO-CHIC-Study BIOmarker driven and dose intensified CHemoImmunotherapy with early CNS prophylaxis in patients less than 65 years with high risk diffuse large B-cell lymphoma | |||||||||||||
Medical condition: Diffuse large B-cell lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Ongoing) DK (Ongoing) SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004100-35 | Sponsor Protocol Number: FSJD-PIOSPIMET-2012 | Start Date*: 2012-12-20 |
Sponsor Name:Fundació per la Recerca i la Docència Sant Joan de Déu | ||
Full Title: A prospective, open-label, randomized, two-armed clinical trial to evaluate the efficacy and safety of a combination of ethinyl-estradiol and levonorgestrel versus a low-dose combination of pioglit... | ||
Medical condition: Ovarian hyperandrogenism | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-000461-28 | Sponsor Protocol Number: Resubmission A | Start Date*: 2008-06-10 | ||||||||||||||||
Sponsor Name:Karolinska institutet | ||||||||||||||||||
Full Title: Effect of exercise or metformin on nocturnal blood pressure and other risk factors for cardiovascular heart disease among obese adolescents | ||||||||||||||||||
Medical condition: The aim is to, among obese adolescents study impact of exercise or metformin therapy on nocturnal blood pressure and related cardiovascular disease risk factors (e.g. insulin sensitivity, IMT, LVM,... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000161-40 | Sponsor Protocol Number: AdrenalClock | Start Date*: 2022-07-18 |
Sponsor Name:Medical University of Vienna, Division of Endocrinology | ||
Full Title: Investigating cardiometabolic risk factors and changes in chronobiology patterns in patients with autonomous adrenal cortisol secretion | ||
Medical condition: Autonomous cortisol secretion in patients with adrenal adenoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000239-28 | Sponsor Protocol Number: D1693C00001 | Start Date*: 2013-07-15 | ||||||||||||||||
Sponsor Name:AstraZeneca AB | ||||||||||||||||||
Full Title: DECLARE Dapagliflozin Effect on CardiovascuLAR Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence o... | ||||||||||||||||||
Medical condition: Type 2 Diabetes mellitus | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) CZ (Completed) IT (Completed) SE (Completed) SK (Completed) BG (Completed) NL (Completed) ES (Completed) DE (Completed) PL (Completed) HU (Completed) BE (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-002160-28 | Sponsor Protocol Number: hepatology_MT_2005-05 | Start Date*: 2005-09-23 |
Sponsor Name:Medical University Graz,Department of Internal Medicine, Division of Gastroenterology and Hepatology | ||
Full Title: Safety and efficacy of long-term treatment with atorvastatin in patients with primary biliary cirrhosis | ||
Medical condition: Reduction of cardiovascular risk may become key for the management of PBC. Therefore information on safety and efficacy (lipid-lowering effects) of statins in chronic cholestatic disorders is essen... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-000882-36 | Sponsor Protocol Number: PAD20001 | Start Date*: 2004-08-05 |
Sponsor Name:GlaxoSmithKine Research & Development Limited | ||
Full Title: A multi-centre, two-staged with interim analysis, parallel, randomised, double blind, placebo-controlled, dose ranging study of the safety, tolerability, and effects on plasma high-density lipoprot... | ||
Medical condition: Treatment of dyslipidaemia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) FI (Completed) LT (Completed) DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-005437-38 | Sponsor Protocol Number: D1250C00008 | Start Date*: 2007-03-07 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Controlled, Randomized, Parallel, Multicentre Study to Assess Safety and Tolerability of the Oral Direct Thrombin Inhibitor AZD0837, given as an Extended-release Formulation, in the Prevention of... | |||||||||||||
Medical condition: Paroxysmal, persistent or permanent nonvalvular atrial fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) SE (Completed) HU (Completed) AT (Completed) DK (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004749-40 | Sponsor Protocol Number: PEDMet 2006-1 | Start Date*: 2006-11-20 |
Sponsor Name:Pediatrics | ||
Full Title: Glucose metabolism in patients with neurological/neuromuscular diseases. | ||
Medical condition: Patients with neurological/neuromuscular diseases | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.